AcquisitionLigand Pharma to acquire Apeiron BiologicsLatest NewsAustrian Apeiron Biologics goes to Ligand Pharmaceuticals for US$100m. Read more 10 July 2024 https://european-biotechnology.com/wp-content/uploads/2024/07/Apeiron_Board.png 540 1110 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-07-10 07:59:522024-07-16 18:27:58Ligand Pharma to acquire Apeiron Biologics
